Cargando…

Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients

BACKGROUND: To evaluate therapeutic outcomes of interferon alpha-2a (IFNα2a) treatment in patients with Behcet’s disease who were refractory to immunosuppressive agents. METHODS: This retrospective case series reviewed the medical records of 5 patients with refractory Behcet uveitis from January 201...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ji Hwan, Lee, Christopher Seungkyu, Lee, Sung Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819294/ https://www.ncbi.nlm.nih.gov/pubmed/29463220 http://dx.doi.org/10.1186/s12886-018-0719-0

Ejemplares similares

Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease
por: Park, Ji-Youn, et al.
Publicado: (2015)

Effectiveness and safety of interferon α2a as an add-on treatment for refractory Behçet’s uveitis
por: Shi, Jing, et al.
Publicado: (2019)

The Effect of Adalimumab in Korean Patients with Refractory Noninfectious Uveitis
por: Park, Sung Eun, et al.
Publicado: (2021)

Bell’s palsy during interferon alpha 2a treatment in a case with Behçet uveitis
por: Yalçindağ, Fatime Nilüfer, et al.
Publicado: (2013)

Comparison of the Safety and Efficacy of Interferon Alpha-2a and Cyclosporine-A When Combined With Glucocorticoid in the Treatment of Refractory Behçet’s Uveitis: A Randomized Controlled Prospective Study
por: Qian, Yujing, et al.
Publicado: (2021)

Interferon-α2a treatment for refractory Behçet's disease
por: Lai, Yung Jen, et al.
Publicado: (2018)

Behçet's Uveitis
por: Tugal-Tutkun, Ilknur
Publicado: (2009)

Spectral domain optical coherence tomography as an adjunctive tool for screening Behçet uveitis
por: Kang, Hae Min, et al.
Publicado: (2018)

Behçet’s Disease Uveitis
por: Joubert, Morgane, et al.
Publicado: (2023)

Successful treatment of Behçet’s uveitis with Tocilizumab
por: Alokaily, F., et al.
Publicado: (2017)

Epidemiology of pediatric uveitis and associated systemic diseases
por: Shin, Yoonkyeom, et al.
Publicado: (2021)

4. A challenging case of refractory BehÇet's disease in an adolescent with sight threatening uveitis
por: Cooper, Gisella, et al.
Publicado: (2018)

Commentary: Behçet’s uveitis – Expanding treatment horizons
por: Moreker, Mayur R
Publicado: (2023)

Macular involvement in patients with Behçet’s uveitis
por: Kahloun, Rim, et al.
Publicado: (2012)

A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome
por: Horiguchi, Noe, et al.
Publicado: (2020)

Cataract surgery under systemic infliximab therapy in patients with refractory uveitis associated with Behcet disease
por: Alfawaz, Abullah, et al.
Publicado: (2014)

Effectiveness and safety of low-dose interferon alpha-2a treatment in Behçet’s Syndrome with refractory vascular or neurological involvement: a case series
por: Sun, Luxi, et al.
Publicado: (2022)

Vitiligo in a Patient Treated with Interferon Alpha-2a for Behçet's Disease
por: Guney, Esra, et al.
Publicado: (2012)

Vitreomacular Interface Disorders in Behçet’s Uveitis
por: Eser Öztürk, Hilal, et al.
Publicado: (2017)

The efficacy of intravitreal interferon alpha-2b for the treatment of experimental endotoxin-induced uveitis
por: Afarid, Mehrdad, et al.
Publicado: (2016)

Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease
por: Sugita, Sunao, et al.
Publicado: (2012)

Topical interferon alpha 2b in the treatment of refractory pseudophakic cystoid macular edema
por: Maleki, Arash, et al.
Publicado: (2018)

Gender Differences in Behçet's Disease Associated Uveitis
por: Ucar-Comlekoglu, Didar, et al.
Publicado: (2014)

Behçet’s Uveitis: Current Diagnostic and Therapeutic Approach
por: Çakar Özdal, Pınar
Publicado: (2020)

Behçet uveitis: Current practice and future perspectives
por: Aboul Naga, Shereen H., et al.
Publicado: (2022)

How challenging can it be to treat Behçet uveitis?
por: Oray, Merih, et al.
Publicado: (2022)

Comparison of Sociodemographic Features Between Behçet Uveitis and Other Non-infectious Uveitis
por: Yalçındağ, F. Nilüfer, et al.
Publicado: (2021)

Adalimumab in Treatment of Uveitis in Pediatric Behcet’s Disease–a Case Report
por: Halilbasic, Meliha, et al.
Publicado: (2021)

P03-009 - Experiences of in pediatric Behçet uveitis
por: Sozeri, B, et al.
Publicado: (2013)

Pattern of Uveitis Associated with Behçet’s Disease in an Egyptian Cohort
por: Abd El Latif, Eiman, et al.
Publicado: (2020)

Old and New Challenges in Uveitis Associated with Behçet’s Disease
por: Gueudry, Julie, et al.
Publicado: (2021)

Renal Manifestations in 2007 Korean Patients with Behçet's Disease
por: Cho, Sung Bin, et al.
Publicado: (2013)

Serum KL-6 elevation in a uveitis patient with Behçet's disease treated with adalimumab
por: Ono, Takashi, et al.
Publicado: (2020)

A novel mechanism of macular holes in patients with Behçet's uveitis
por: Alsarhani, Waleed K., et al.
Publicado: (2022)

Genetic Association of Interleukin 33/ST2 Polymorphisms With Behcet’s Uveitis
por: Pei, Minghang, et al.
Publicado: (2021)

Intercellular adhesion molecule-1 polymorphisms in Korean patients with Behcet s disease.
por: Kim, Eun Hee, et al.
Publicado: (2003)

Topical Interferon Alpha 2b in the Treatment of Refractory Diabetic Macular Edema
por: Maleki, Arash, et al.
Publicado: (2020)

The Behçet's Disease Quality of Life: Reliability and Validity of the Korean Version
por: Yi, Sang Won, et al.
Publicado: (2008)

Reconstitution of disrupted photoreceptor layer in uveitis associated with Behçet’s disease by infliximab treatment
por: Takeuchi, Masaru, et al.
Publicado: (2015)

Role of Adalimumab Biosimilar in the Treatment of Non-Anterior Uveitis Associated with Behçet’s Syndrome
por: Sota, Jurgen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5ijmsum66713ivj2ehftgi4h6e